Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiotis Efentakis

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|January 27, 2016
Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective AgentsNikolaos Lougiakis, Andreas Papapetropoulos, Evangelos Gikas, et al.
Nutrients|July 13, 2024
Antihypertensive Potential of <i>Pistacia lentiscus</i> var. <i>Chia</i>: Molecular Insights and Therapeutic ImplicationsPanagiotis Efentakis, Lydia Symeonidi, Despoina D Gianniou, et al.
Phytotherapy Research : PTR|May 29, 2026
Preclinical Evaluation of Berry Extracts as a Nutritional Intervention to Alleviate Myocardial Ischemia-Reperfusion Injury and Atherosclerosis DevelopmentLydia Symeonidi, Panagiota-Efstathia Nikolaou, Panagiotis Stathopoulos, et al.
Oxidative Medicine and Cellular Longevity|August 10, 2019
T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of <sup>·</sup>NO/cGMP SignalingRebecca Schüler, Panagiotis Efentakis, Johannes Wild, et al.
Frontiers in Physiology|January 10, 2018
Empagliflozin Limits Myocardial Infarction <i>in Vivo</i> and Cell Death <i>in Vitro</i>: Role of STAT3, Mitochondria, and Redox AspectsIoanna Andreadou, Panagiotis Efentakis, Evangelos Balafas, et al.
Cardiovascular Research|March 8, 2019
Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitorsPanagiota-Efstathia Nikolaou, Kerstin Boengler, Panagiotis Efentakis, et al.
Journal of Medicinal Chemistry|November 9, 2023
Hydrolytic Activity of Mitochondrial F<sub>1</sub>F<sub>O</sub>-ATP Synthase as a Target for Myocardial Ischemia-Reperfusion Injury: Discovery and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel InhibitorsPanagiota-Efstathia Nikolaou, George Lambrinidis, Maria Georgiou, et al.
Drug Design, Development and Therapy|July 3, 2025
Cardioprotection Through Pharmacological Activation of Sirtuin 5 in a Murine Model of Acute Myocardial InfarctionCarola Castiello, Panagiotis Efentakis, Panagiota-Efstathia Nikolaou, et al.
Cardiovascular Research|June 23, 2019
Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropyPanagiotis Efentakis, Aimilia Varela, Evangelia Chavdoula, et al.
Basic Research in Cardiology|February 6, 2021
Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning studyIgnatios Ikonomidis, Dimitrios Vlastos, Ioanna Andreadou, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|January 27, 2016
Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective AgentsNikolaos Lougiakis, Andreas Papapetropoulos, Evangelos Gikas, et al.
Nutrients|July 13, 2024
Antihypertensive Potential of <i>Pistacia lentiscus</i> var. <i>Chia</i>: Molecular Insights and Therapeutic ImplicationsPanagiotis Efentakis, Lydia Symeonidi, Despoina D Gianniou, et al.
Phytotherapy Research : PTR|May 29, 2026
Preclinical Evaluation of Berry Extracts as a Nutritional Intervention to Alleviate Myocardial Ischemia-Reperfusion Injury and Atherosclerosis DevelopmentLydia Symeonidi, Panagiota-Efstathia Nikolaou, Panagiotis Stathopoulos, et al.
Oxidative Medicine and Cellular Longevity|August 10, 2019
T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of <sup>·</sup>NO/cGMP SignalingRebecca Schüler, Panagiotis Efentakis, Johannes Wild, et al.
Frontiers in Physiology|January 10, 2018
Empagliflozin Limits Myocardial Infarction <i>in Vivo</i> and Cell Death <i>in Vitro</i>: Role of STAT3, Mitochondria, and Redox AspectsIoanna Andreadou, Panagiotis Efentakis, Evangelos Balafas, et al.
Cardiovascular Research|March 8, 2019
Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitorsPanagiota-Efstathia Nikolaou, Kerstin Boengler, Panagiotis Efentakis, et al.
Journal of Medicinal Chemistry|November 9, 2023
Hydrolytic Activity of Mitochondrial F<sub>1</sub>F<sub>O</sub>-ATP Synthase as a Target for Myocardial Ischemia-Reperfusion Injury: Discovery and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel InhibitorsPanagiota-Efstathia Nikolaou, George Lambrinidis, Maria Georgiou, et al.
Drug Design, Development and Therapy|July 3, 2025
Cardioprotection Through Pharmacological Activation of Sirtuin 5 in a Murine Model of Acute Myocardial InfarctionCarola Castiello, Panagiotis Efentakis, Panagiota-Efstathia Nikolaou, et al.
Cardiovascular Research|June 23, 2019
Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropyPanagiotis Efentakis, Aimilia Varela, Evangelia Chavdoula, et al.
Basic Research in Cardiology|February 6, 2021
Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning studyIgnatios Ikonomidis, Dimitrios Vlastos, Ioanna Andreadou, et al.
Pageof 5